<s id="wsj_1028.1"> 37
3 	 0 	 N/N 	 1 	 Inc. American
3 	 1 	 N/N 	 1 	 Inc. Medical
3 	 2 	 N/N 	 1 	 Inc. International
3 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 Inc. said
3 	 22 	 (S[dcl]\NP)/NP 	 1 	 Inc. took <XU>
5 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 it has
5 	 8 	 (S[pt]\NP)/NP 	 1 	 it received <XB>
6 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 has said
6 	 7 	 (S\NP)\(S\NP) 	 2 	 has n't
8 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 received has
11 	 8 	 (S[pt]\NP)/NP 	 2 	 offers received
11 	 9 	 NP[nb]/N 	 1 	 offers any
11 	 10 	 N/N 	 1 	 offers other
11 	 13 	 (S[b]\NP)/NP 	 1 	 offers acquire <XB>
13 	 12 	 (S[to]\NP)/(S[b]\NP) 	 2 	 acquire to
15 	 13 	 (S[b]\NP)/NP 	 2 	 owner acquire
15 	 14 	 NP[nb]/N 	 1 	 owner the
15 	 18 	 (NP\NP)/NP 	 1 	 owner of
17 	 13 	 (S[b]\NP)/NP 	 2 	 operator acquire
17 	 14 	 NP[nb]/N 	 1 	 operator the
17 	 18 	 (NP\NP)/NP 	 1 	 operator of
19 	 18 	 (NP\NP)/NP 	 2 	 hospitals of
24 	 22 	 (S[dcl]\NP)/NP 	 2 	 step took
24 	 23 	 NP[nb]/N 	 1 	 step another
24 	 25 	 (NP\NP)/NP 	 1 	 step toward
26 	 25 	 (NP\NP)/NP 	 2 	 completion toward
26 	 27 	 (NP\NP)/NP 	 1 	 completion of
31 	 29 	 (N/N)/N[num] 	 2 	 billion $
31 	 30 	 N/N 	 1 	 billion 3
32 	 27 	 (NP\NP)/NP 	 2 	 acquisition of
32 	 28 	 NP[nb]/N 	 1 	 acquisition its
32 	 29 	 (N/N)/N[num] 	 1 	 acquisition $
32 	 33 	 (NP\NP)/NP 	 1 	 acquisition by
36 	 33 	 (NP\NP)/NP 	 2 	 Corp by
36 	 34 	 N/N 	 1 	 Corp IMA
36 	 35 	 N/N 	 1 	 Corp Holdings
<\s>
<s id="wsj_1028.2"> 34
1 	 0 	 (S/S)/(S/S) 	 2 	 this Earlier
2 	 1 	 (S/S)/N 	 2 	 month this
3 	 19 	 (S[dcl]\NP)/NP 	 1 	 IMA submitted
7 	 5 	 NP[nb]/N 	 1 	 group an
7 	 6 	 N/N 	 1 	 group investment
7 	 8 	 (NP\NP)/(S[dcl]\NP) 	 1 	 group that
7 	 9 	 (S[dcl]\NP)/NP 	 1 	 group includes <XB>
7 	 19 	 (S[dcl]\NP)/NP 	 1 	 group submitted
9 	 8 	 (NP\NP)/(S[dcl]\NP) 	 2 	 includes that
10 	 11 	 (NP[nb]/N)\NP 	 2 	 Chicago 's
13 	 9 	 (S[dcl]\NP)/NP 	 2 	 family includes
13 	 11 	 (NP[nb]/N)\NP 	 1 	 family 's
13 	 12 	 N/N 	 1 	 family Pritzker
17 	 9 	 (S[dcl]\NP)/NP 	 2 	 Corp. includes
17 	 15 	 N/N 	 1 	 Corp. First
17 	 16 	 N/N 	 1 	 Corp. Boston
19 	 1 	 (S/S)/N 	 1 	 submitted this
19 	 26 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 submitted after
22 	 19 	 (S[dcl]\NP)/NP 	 2 	 bid submitted
22 	 20 	 NP[nb]/N 	 1 	 bid a
22 	 21 	 N/N 	 1 	 bid reduced
22 	 23 	 (NP\NP)/NP 	 1 	 bid for
25 	 23 	 (NP\NP)/NP 	 2 	 Medical for
25 	 24 	 N/N 	 1 	 Medical American
27 	 28 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it could
27 	 30 	 (S[b]\NP)/NP 	 1 	 it finance <XB>
28 	 26 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 could after
28 	 29 	 (S\NP)\(S\NP) 	 2 	 could n't
30 	 28 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 finance could
33 	 30 	 (S[b]\NP)/NP 	 2 	 offer finance
33 	 31 	 NP[nb]/N 	 1 	 offer its
33 	 32 	 N/N 	 1 	 offer initial
<\s>
<s id="wsj_1028.3"> 25
3 	 0 	 (S/S)/NP 	 2 	 offer Under
3 	 1 	 NP[nb]/N 	 1 	 offer the
3 	 2 	 N/N 	 1 	 offer new
5 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 IMA will
5 	 7 	 ((S[b]\NP)/PP)/NP 	 1 	 IMA pay <XB>
6 	 0 	 (S/S)/NP 	 1 	 will Under
7 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 pay will
8 	 7 	 ((S[b]\NP)/PP)/NP 	 3 	 $ pay
8 	 10 	 (NP\NP)/N 	 1 	 $ a
9 	 8 	 N/N[num] 	 1 	 26.50 $
11 	 10 	 (NP\NP)/N 	 2 	 share a
12 	 7 	 ((S[b]\NP)/PP)/NP 	 2 	 for pay
14 	 13 	 (N/N)/(N/N) 	 2 	 million 63
15 	 12 	 PP/NP 	 1 	 shares for
15 	 14 	 N/N 	 1 	 shares million
19 	 18 	 (N/N)/(N/N) 	 2 	 86 about
20 	 12 	 PP/NP 	 1 	 % for
20 	 19 	 N/N 	 1 	 % 86
20 	 21 	 (NP\NP)/NP 	 1 	 % of
23 	 21 	 (NP\NP)/NP 	 2 	 shares of
23 	 22 	 NP[nb]/N 	 1 	 shares the
23 	 24 	 S[adj]\NP 	 1 	 shares outstanding <XB>
<\s>
<s id="wsj_1028.4"> 9
0 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 IMA will
0 	 3 	 (S[b]\NP)/NP 	 1 	 IMA assume <XB>
2 	 1 	 (S\NP)/(S\NP) 	 2 	 will also
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 assume will
4 	 3 	 (S[b]\NP)/NP 	 2 	 $ assume
4 	 7 	 (NP\NP)/NP 	 1 	 $ in
6 	 4 	 N/N[num] 	 1 	 billion $
6 	 5 	 N/N 	 1 	 billion 1.4
8 	 7 	 (NP\NP)/NP 	 2 	 debt in
<\s>
<s id="wsj_1028.5"> 29
4 	 2 	 (S/S)/NP 	 2 	 trading in
4 	 3 	 N/N 	 1 	 trading composite
4 	 5 	 (NP\NP)/NP 	 1 	 trading on
10 	 5 	 (NP\NP)/NP 	 2 	 Exchange on
10 	 6 	 NP[nb]/N 	 1 	 Exchange the
10 	 7 	 N/N 	 1 	 Exchange New
10 	 8 	 N/N 	 1 	 Exchange York
10 	 9 	 N/N 	 1 	 Exchange Stock
13 	 12 	 N/N 	 1 	 common AMI
13 	 14 	 (S[dcl]\NP)/PP 	 1 	 common closed
14 	 0 	 S/S 	 1 	 closed Yesterday
14 	 2 	 (S/S)/NP 	 1 	 closed in
14 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 closed up
14 	 23 	 ((S\NP)\(S\NP))/NP 	 2 	 closed on
15 	 14 	 (S[dcl]\NP)/PP 	 2 	 at closed
16 	 15 	 PP/NP 	 1 	 $ at
17 	 16 	 N/N[num] 	 1 	 23.625 $
21 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 cents up
21 	 20 	 N/N 	 1 	 cents 12.5
24 	 23 	 ((S\NP)\(S\NP))/NP 	 3 	 volume on
24 	 25 	 (NP\NP)/NP 	 1 	 volume of
28 	 25 	 (NP\NP)/NP 	 2 	 million of
28 	 26 	 N/N 	 1 	 million almost
28 	 27 	 N/N 	 1 	 million 1.8
<\s>
<s id="wsj_1028.6"> 30
3 	 2 	 N/N 	 1 	 Medical American
3 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 Medical said
4 	 0 	 S/S 	 1 	 said Earlier
5 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 it had
5 	 8 	 S[pss]\NP 	 1 	 it approached <XB>
6 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 had said
7 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been had
8 	 7 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 approached been
8 	 9 	 (S\NP)\(S\NP) 	 2 	 approached again
8 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 approached by
14 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 suitors by
14 	 11 	 N/N 	 1 	 suitors two
14 	 12 	 N/N 	 1 	 suitors other
14 	 13 	 N/N 	 1 	 suitors possible
14 	 16 	 (NP\NP)/(S[dcl]/NP) 	 1 	 suitors whom
14 	 20 	 (S[b]\NP)/NP 	 2 	 suitors identify <XU>
14 	 22 	 (NP\NP)/(S[dcl]\NP) 	 1 	 suitors who <XU>
14 	 23 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 suitors had <XU>
14 	 25 	 (S[pt]\NP)/NP 	 1 	 suitors submitted <XU>
17 	 18 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it would
17 	 20 	 (S[b]\NP)/NP 	 1 	 it identify <XB>
18 	 16 	 (NP\NP)/(S[dcl]/NP) 	 2 	 would whom
18 	 19 	 (S\NP)\(S\NP) 	 2 	 would n't
20 	 18 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 identify would
23 	 22 	 (NP\NP)/(S[dcl]\NP) 	 2 	 had who
23 	 24 	 (S\NP)\(S\NP) 	 2 	 had previously
25 	 23 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 submitted had
26 	 25 	 (S[pt]\NP)/NP 	 2 	 bids submitted
26 	 27 	 (NP\NP)/NP 	 1 	 bids for
29 	 27 	 (NP\NP)/NP 	 2 	 company for
29 	 28 	 NP[nb]/N 	 1 	 company the
<\s>
<s id="wsj_1028.7"> 26
3 	 2 	 N/N 	 1 	 Medical American
3 	 4 	 (S[dcl]\NP)/S[em] 	 1 	 Medical said
4 	 0 	 S/S 	 1 	 said Yesterday
5 	 4 	 (S[dcl]\NP)/S[em] 	 2 	 that said
9 	 6 	 NP[nb]/N 	 1 	 parties the
9 	 7 	 N/N 	 1 	 parties two
9 	 8 	 N/N 	 1 	 parties other
9 	 10 	 ((S[dcl]\NP)/S[em])/NP 	 1 	 parties told
10 	 5 	 S[em]/S[dcl] 	 1 	 told that
12 	 10 	 ((S[dcl]\NP)/S[em])/NP 	 3 	 company told
12 	 11 	 NP[nb]/N 	 1 	 company the
13 	 10 	 ((S[dcl]\NP)/S[em])/NP 	 2 	 that told
14 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 they do
14 	 17 	 (S[b]\NP)/NP 	 1 	 they have <XB>
15 	 13 	 S[em]/S[dcl] 	 1 	 do that
15 	 16 	 (S\NP)\(S\NP) 	 2 	 do n't
17 	 15 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 have do
20 	 17 	 (S[b]\NP)/NP 	 2 	 intention have
20 	 18 	 NP[nb]/N 	 1 	 intention any
20 	 19 	 N/N 	 1 	 intention current
20 	 21 	 (NP\NP)/(S[ng]\NP) 	 1 	 intention of
22 	 21 	 (NP\NP)/(S[ng]\NP) 	 2 	 making of
25 	 22 	 (S[ng]\NP)/NP 	 2 	 bid making
25 	 23 	 NP[nb]/N 	 1 	 bid a
25 	 24 	 N/N 	 1 	 bid takeover
<\s>
<s id="wsj_1028.8"> 41
1 	 0 	 N/N 	 1 	 Medical American
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 Medical said
4 	 3 	 NP[nb]/N 	 1 	 directors its
4 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 directors have
4 	 6 	 (S[pt]\NP)/NP 	 1 	 directors approved <XB>
5 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 have said
6 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 approved have
7 	 6 	 (S[pt]\NP)/NP 	 2 	 what approved
7 	 8 	 (S[dcl]\NP)/NP 	 1 	 what is <XB>
8 	 7 	 NP/(S[dcl]\NP) 	 1 	 is what
8 	 10 	 ((S\NP)\(S\NP))/NP 	 2 	 is in
11 	 10 	 ((S\NP)\(S\NP))/NP 	 3 	 effect in
14 	 8 	 (S[dcl]\NP)/NP 	 2 	 draft is
14 	 13 	 NP[nb]/N 	 1 	 draft a
14 	 15 	 (NP\NP)/NP 	 1 	 draft of
14 	 23 	 S[pss]\NP 	 1 	 draft submitted <XB>
18 	 15 	 (NP\NP)/NP 	 2 	 opinion of
18 	 16 	 NP[nb]/N 	 1 	 opinion a
18 	 17 	 N/N 	 1 	 opinion solvency
18 	 19 	 (NP\NP)/NP 	 1 	 opinion on
21 	 19 	 (NP\NP)/NP 	 2 	 acquisition on
21 	 20 	 NP[nb]/N 	 1 	 acquisition the
23 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 submitted by
27 	 26 	 (N/N)/(N/N) 	 2 	 Angeles-based Los
29 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 banking by
29 	 25 	 NP[nb]/N 	 1 	 banking the
29 	 27 	 N/N 	 1 	 banking Angeles-based
29 	 28 	 N/N 	 1 	 banking investment
29 	 34 	 (NP\NP)/NP 	 1 	 banking of
33 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 firm by
33 	 25 	 NP[nb]/N 	 1 	 firm the
33 	 27 	 N/N 	 1 	 firm Angeles-based
33 	 28 	 N/N 	 1 	 firm investment
33 	 31 	 N/N 	 1 	 firm evaluation
33 	 32 	 N/N 	 1 	 firm consulting
33 	 34 	 (NP\NP)/NP 	 1 	 firm of
40 	 34 	 (NP\NP)/NP 	 2 	 Inc of
40 	 35 	 N/N 	 1 	 Inc Houlian
40 	 36 	 N/N 	 1 	 Inc Lokey
40 	 37 	 N/N 	 1 	 Inc Howard
40 	 38 	 N/N 	 1 	 Inc &
40 	 39 	 N/N 	 1 	 Inc Zukin
<\s>
<s id="wsj_1028.9"> 29
2 	 0 	 NP[nb]/N 	 1 	 opinion A
2 	 1 	 N/N 	 1 	 opinion final
2 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 opinion must
2 	 5 	 S[pss]\NP 	 1 	 opinion approved <XB>
4 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be must
5 	 4 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 approved be
5 	 6 	 ((S\NP)\(S\NP))/PP 	 2 	 approved prior
7 	 6 	 ((S\NP)\(S\NP))/PP 	 3 	 to prior
9 	 7 	 PP/NP 	 1 	 acceptance to
9 	 8 	 NP[nb]/N 	 1 	 acceptance the
9 	 10 	 (NP\NP)/NP 	 1 	 acceptance of
9 	 13 	 (NP\NP)/NP 	 1 	 acceptance for
9 	 15 	 (NP\NP)/NP 	 1 	 acceptance under
12 	 10 	 (NP\NP)/NP 	 2 	 shares of
12 	 11 	 N/N 	 1 	 shares tendered
14 	 13 	 (NP\NP)/NP 	 2 	 payment for
17 	 15 	 (NP\NP)/NP 	 2 	 offer under
17 	 16 	 NP[nb]/N 	 1 	 offer the
17 	 19 	 (NP\NP)/(S[dcl]\NP) 	 1 	 offer which
17 	 20 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 offer was <XB>
17 	 21 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 offer due <XB>
20 	 19 	 (NP\NP)/(S[dcl]\NP) 	 2 	 was which
21 	 20 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 due was
22 	 21 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to due
23 	 22 	 (S[to]\NP)/(S[b]\NP) 	 2 	 expire to
23 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 expire at
27 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 EDT at
27 	 25 	 N/N 	 1 	 EDT 12:01
27 	 26 	 N/N 	 1 	 EDT a.m.
27 	 28 	 NP\NP 	 1 	 EDT today
<\s>
<s id="wsj_1028.10"> 25
2 	 3 	 (NP[nb]/N)\NP 	 2 	 Moody 's
6 	 3 	 (NP[nb]/N)\NP 	 1 	 Inc. 's
6 	 4 	 N/N 	 1 	 Inc. Investors
6 	 5 	 N/N 	 1 	 Inc. Service
6 	 7 	 (S[dcl]\NP)/NP 	 1 	 Inc. downgraded
7 	 0 	 S/S 	 1 	 downgraded Separately
9 	 7 	 (S[dcl]\NP)/NP 	 2 	 ratings downgraded
9 	 8 	 NP[nb]/N 	 1 	 ratings the
9 	 10 	 (NP\NP)/NP 	 1 	 ratings of
12 	 11 	 N/N 	 1 	 Medical American
12 	 13 	 (NP[nb]/N)\NP 	 2 	 Medical 's
18 	 10 	 (NP\NP)/NP 	 2 	 issues of
18 	 13 	 (NP[nb]/N)\NP 	 1 	 issues 's
18 	 14 	 N/N 	 1 	 issues senior <XU>
18 	 16 	 N/N 	 1 	 issues subordinated
18 	 17 	 N/N 	 1 	 issues debt
20 	 7 	 (S[dcl]\NP)/NP 	 2 	 those downgraded
20 	 21 	 (NP\NP)/NP 	 1 	 those of
24 	 21 	 (NP\NP)/NP 	 2 	 affiliate of
24 	 22 	 NP[nb]/N 	 1 	 affiliate its
24 	 23 	 N/N 	 1 	 affiliate international
<\s>
<s id="wsj_1028.11"> 14
1 	 0 	 NP[nb]/N 	 1 	 downgrade The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 downgrade anticipates
2 	 13 	 (S[dcl]\S[dcl])\NP 	 1 	 anticipates said
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 completion anticipates
3 	 4 	 (NP\NP)/NP 	 1 	 completion of
3 	 9 	 NP\NP 	 1 	 completion today
8 	 4 	 (NP\NP)/NP 	 2 	 acquisition of
8 	 5 	 NP[nb]/N 	 1 	 acquisition the
8 	 6 	 N/N 	 1 	 acquisition IMA
8 	 7 	 N/N 	 1 	 acquisition Holdings
12 	 11 	 N/N 	 1 	 's Moody
12 	 13 	 (S[dcl]\S[dcl])\NP 	 2 	 's said
<\s>
<s id="wsj_1028.12"> 47
2 	 0 	 NP[nb]/N 	 1 	 concern The
2 	 1 	 N/N 	 1 	 concern ratings
2 	 3 	 (S[dcl]\NP)/S[dcl] 	 1 	 concern said
5 	 4 	 NP[nb]/N 	 1 	 acquisition the
5 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 acquisition should
5 	 7 	 (S[b]\NP)/PP 	 1 	 acquisition result <XB>
6 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 should said
7 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 result should
7 	 13 	 ((S\NP)\(S\NP))/PP 	 2 	 result because
8 	 7 	 (S[b]\NP)/PP 	 2 	 in result
10 	 8 	 PP/NP 	 1 	 losses in
10 	 9 	 N/N 	 1 	 losses pretax
10 	 11 	 (NP\NP)/NP 	 1 	 losses from
12 	 11 	 (NP\NP)/NP 	 2 	 operations from
14 	 13 	 ((S\NP)\(S\NP))/PP 	 3 	 of because
15 	 14 	 PP/NP 	 1 	 increases of
15 	 16 	 (NP\NP)/NP 	 1 	 increases in
18 	 16 	 (NP\NP)/NP 	 2 	 expense in
18 	 17 	 N/N 	 1 	 expense interest
20 	 14 	 PP/NP 	 1 	 charges of
20 	 21 	 (NP\NP)/NP 	 1 	 charges for
22 	 21 	 (NP\NP)/NP 	 2 	 depreciation for
24 	 21 	 (NP\NP)/NP 	 2 	 amortization for
27 	 3 	 (S[dcl]\NP)/S[dcl] 	 2 	 that said
28 	 29 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 1 	 it expects
29 	 27 	 S[em]/S[dcl] 	 1 	 expects that
31 	 29 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 3 	 losses expects
31 	 30 	 NP[nb]/N 	 1 	 losses the
31 	 34 	 S[pss]\NP 	 1 	 losses reduced <XB>
32 	 29 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 2 	 to expects
33 	 32 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
34 	 33 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 reduced be
34 	 35 	 ((S\NP)\(S\NP))/NP 	 2 	 reduced through
37 	 35 	 ((S\NP)\(S\NP))/NP 	 3 	 gains through
37 	 36 	 N/N 	 1 	 gains productivity
40 	 39 	 (N/N)/(N/N) 	 2 	 average above
41 	 35 	 ((S\NP)\(S\NP))/NP 	 3 	 growth through
41 	 40 	 N/N 	 1 	 growth average
41 	 42 	 (NP\NP)/NP 	 1 	 growth of
44 	 43 	 NP[nb]/N 	 1 	 company the
44 	 45 	 (NP[nb]/N)\NP 	 2 	 company 's
46 	 42 	 (NP\NP)/NP 	 2 	 hospitals of
46 	 45 	 (NP[nb]/N)\NP 	 1 	 hospitals 's
<\s>
<s id="wsj_1028.13"> 22
1 	 0 	 N/N 	 1 	 's Moody
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 's said
4 	 3 	 NP[nb]/N 	 1 	 ratings the
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 ratings anticipate
5 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 anticipate said
9 	 5 	 (S[dcl]\NP)/NP 	 2 	 program anticipate
9 	 6 	 NP[nb]/N 	 1 	 program a
9 	 7 	 N/N 	 1 	 program successful
9 	 8 	 N/N 	 1 	 program debt-reduction
12 	 5 	 (S[dcl]\NP)/NP 	 2 	 improvement anticipate
12 	 11 	 N/N 	 1 	 improvement modest
12 	 13 	 (NP\NP)/NP 	 1 	 improvement in
12 	 17 	 (NP\NP)/PP 	 1 	 improvement because
16 	 13 	 (NP\NP)/NP 	 2 	 flow in
16 	 14 	 N/N 	 1 	 flow discretionary
16 	 15 	 N/N 	 1 	 flow cash
18 	 17 	 (NP\NP)/PP 	 2 	 of because
21 	 18 	 PP/NP 	 1 	 sales of
21 	 19 	 N/N 	 1 	 sales planned
21 	 20 	 N/N 	 1 	 sales asset
<\s>
<s id="wsj_1028.14"> 7
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Moody 's
2 	 1 	 (NP[nb]/N)\NP 	 1 	 changes 's
2 	 3 	 (S[dcl]\NP)/NP 	 1 	 changes affected
6 	 3 	 (S[dcl]\NP)/NP 	 2 	 issues affected
6 	 4 	 NP[nb]/N 	 1 	 issues the
6 	 5 	 N/N 	 1 	 issues following
<\s>
<s id="wsj_1028.15"> 40
2 	 0 	 N/N 	 1 	 International American
2 	 1 	 N/N 	 1 	 International Medical
2 	 3 	 (NP\NP)/NP 	 1 	 International :
5 	 3 	 (NP\NP)/NP 	 2 	 notes :
5 	 4 	 N/N 	 1 	 notes Senior
5 	 22 	 (NP\NP)/(S[adj]\NP) 	 1 	 notes to
5 	 24 	 (NP\NP)/(S[adj]\NP) 	 1 	 notes from
8 	 3 	 (NP\NP)/NP 	 2 	 debentures :
8 	 7 	 N/N 	 1 	 debentures sinking-fund
8 	 22 	 (NP\NP)/(S[adj]\NP) 	 1 	 debentures to
8 	 24 	 (NP\NP)/(S[adj]\NP) 	 1 	 debentures from
11 	 3 	 (NP\NP)/NP 	 2 	 notes :
11 	 10 	 N/N 	 1 	 notes Euromarket
11 	 22 	 (NP\NP)/(S[adj]\NP) 	 1 	 notes to
11 	 24 	 (NP\NP)/(S[adj]\NP) 	 1 	 notes from
13 	 3 	 (NP\NP)/NP 	 2 	 Eurobonds :
13 	 22 	 (NP\NP)/(S[adj]\NP) 	 1 	 Eurobonds to
13 	 24 	 (NP\NP)/(S[adj]\NP) 	 1 	 Eurobonds from
17 	 3 	 (NP\NP)/NP 	 2 	 bonds :
17 	 15 	 N/N 	 1 	 bonds Swiss
17 	 16 	 N/N 	 1 	 bonds franc
17 	 22 	 (NP\NP)/(S[adj]\NP) 	 1 	 bonds to
17 	 24 	 (NP\NP)/(S[adj]\NP) 	 1 	 bonds from
21 	 3 	 (NP\NP)/NP 	 2 	 stock :
21 	 19 	 N/N 	 1 	 stock unsecured
21 	 20 	 N/N 	 1 	 stock loan
21 	 22 	 (NP\NP)/(S[adj]\NP) 	 1 	 stock to
21 	 24 	 (NP\NP)/(S[adj]\NP) 	 1 	 stock from
23 	 22 	 (NP\NP)/(S[adj]\NP) 	 2 	 Ba3 to
25 	 24 	 (NP\NP)/(S[adj]\NP) 	 2 	 Baa2 from
29 	 3 	 (NP\NP)/NP 	 2 	 debentures :
29 	 27 	 N/N 	 1 	 debentures convertible
29 	 28 	 N/N 	 1 	 debentures subordinated
29 	 36 	 (NP\NP)/(S[adj]\NP) 	 1 	 debentures to
29 	 38 	 (NP\NP)/(S[adj]\NP) 	 1 	 debentures from
31 	 3 	 (NP\NP)/NP 	 2 	 notes :
31 	 36 	 (NP\NP)/(S[adj]\NP) 	 1 	 notes to
31 	 38 	 (NP\NP)/(S[adj]\NP) 	 1 	 notes from
35 	 3 	 (NP\NP)/NP 	 2 	 debentures :
35 	 34 	 N/N 	 1 	 debentures sinking-fund
35 	 36 	 (NP\NP)/(S[adj]\NP) 	 1 	 debentures to
35 	 38 	 (NP\NP)/(S[adj]\NP) 	 1 	 debentures from
37 	 36 	 (NP\NP)/(S[adj]\NP) 	 2 	 B2 to
39 	 38 	 (NP\NP)/(S[adj]\NP) 	 2 	 Baa3 from
<\s>
<s id="wsj_1028.16"> 11
3 	 0 	 N/N 	 1 	 N.V. American
3 	 1 	 N/N 	 1 	 N.V. Medical
3 	 2 	 N/N 	 1 	 N.V. International
3 	 4 	 (NP\NP)/NP 	 1 	 N.V. :
6 	 4 	 (NP\NP)/NP 	 2 	 Euroissues :
6 	 5 	 N/N 	 1 	 Euroissues Guaranteed
6 	 7 	 (NP\NP)/(S[adj]\NP) 	 1 	 Euroissues to
6 	 9 	 (NP\NP)/(S[adj]\NP) 	 1 	 Euroissues from
8 	 7 	 (NP\NP)/(S[adj]\NP) 	 2 	 Ba3 to
10 	 9 	 (NP\NP)/(S[adj]\NP) 	 2 	 Baa2 from
<\s>
<s id="wsj_1028.17"> 18
3 	 0 	 NP[nb]/N 	 1 	 spokeswoman An
3 	 1 	 N/N 	 1 	 spokeswoman American
3 	 2 	 N/N 	 1 	 spokeswoman Medical
3 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 spokeswoman said
6 	 5 	 NP[nb]/N 	 1 	 Moody the
6 	 7 	 (NP[nb]/N)\NP 	 2 	 Moody 's
8 	 7 	 (NP[nb]/N)\NP 	 1 	 downgrading 's
8 	 9 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 downgrading was
8 	 10 	 S[pss]\NP 	 1 	 downgrading expected <XB>
9 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 was said
10 	 9 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 expected was
10 	 11 	 ((S\NP)\(S\NP))/PP 	 2 	 expected because
12 	 11 	 ((S\NP)\(S\NP))/PP 	 3 	 of because
14 	 12 	 PP/NP 	 1 	 nature of
14 	 13 	 NP[nb]/N 	 1 	 nature the
14 	 15 	 (NP\NP)/NP 	 1 	 nature of
17 	 15 	 (NP\NP)/NP 	 2 	 takeover of
17 	 16 	 NP[nb]/N 	 1 	 takeover the
<\s>
